 |
|
May 12, 1999
JAMA. 1999;281:1765-1766.
Physicians in the United States, Canada, and Mexico
Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of JAMA, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for category 1 CME credit. There is no charge.
The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor CME for physicians. The AMA designates this educational activity for up to 1 hour of category 1 CME credit per JAMA issue toward the AMA Physician's Recognition Award (PRA). Each physician should claim for credit only those hours that were actually spent in this educational activity.
Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for CME credit even if they live or practice in other countries. Physicians licensed in other countries are also welcome to participate in this CME activity. However, the PRA is available only to physicians licensed in the United States, Canada, or Mexico.
Earning Credit and the CME Evaluation Form
To earn credit, read 3 of the articles listed below that are designated for CME credit carefully and complete the CME Evaluation Form. The CME Evaluation Form must be submitted within 1 month of the issue date. A certificate awarding 1 hour of category 1 CME credit will be faxed or mailed to you; it is then your responsibility to maintain a record of credit received.
One of our goals is to assess continually the educational needs of our readers so we may enhance the educational effectiveness of JAMA. To achieve this goal, we need your help. You must complete the CME Evaluation Form to receive credit.
Statement of Educational Purpose
JAMA is a general medical journal. Its mission and educational purpose is to promote the science and art of medicine and the betterment of the public health. A flexible curriculum of article topics is developed annually by THE JOURNAL's editorial board and is then supplemented throughout the year with information gained from readers, authors, reviewers, and editors. To accommodate the diversity of practice types within JAMA's readership, the Reader's Choice CME activity allows readers, as adult learners, to determine their own educational needs and to assist the editors in addressing their needs in future issues.
Readers of JAMA should be able to attain the following educational objectives: (1) select and read at least 3 articles in 1 issue to gain new medical information on topics of particular interest to them as physicians, (2) assess the articles' value to them as practicing physicians, and (3) think carefully about how this new information may influence their own practices. The educational objective for each CME article is given after the article title below.
CME Articles in This Issue of JAMA
The following articles in this issue may be read for CME credit:
Diabetes Care and Patient-Oriented Outcomes (SEE ARTICLE)
Educational Objective: To learn about recent advances in the management of diabetes mellitus based on patient outcomes.
First Unaffected Pregnancy Using Preimplantation Genetic Diagnosis for Sickle Cell Anemia (SEE ARTICLE)
Educational Objective: To learn how genetic defects may be prevented without abortion.
Depressed Adolescents Grown Up (SEE ARTICLE)
Educational Objective: To learn about the long-term sequelae of adolescent depression.
The Definition of Anemia in Older Persons (SEE ARTICLE)
Educational Objective: To understand that anemia in old age is associated with increased mortality.
Malondialdehyde-Modified LDL as a Marker of Acute Coronary Syndromes (SEE ARTICLE)
Educational Objective: To learn that this marker can help discriminate stable coronary artery disease from acute coronary syndromes.
The Safety of Newly Approved Medicines: Do Recent Market Removals Mean There Is a Problem? (SEE ARTICLE)
Educational Objective: To learn that recent market removals may not indicate flaws in the drug review process.
Anthrax as a Biological Weapon: Medical and Public Health Management (SEE ARTICLE)
Educational Objective: To learn an expert panel's recommendations for the control of epidemic anthrax.
Advances in Molecular Genetics and Management of Hypertrophic Cardiomyopathy (SEE ARTICLE)
Educational Objective: To review the clinical management of hypertrophic cardiomyopathy.
RELATED ARTICLES
Diabetes Care and Patient-Oriented Outcomes
Michael Berger and Ingrid Mühlhauser
JAMA. 1999;281(18):1676-1678.
EXTRACT
| FULL TEXT
First Unaffected Pregnancy Using Preimplantation Genetic Diagnosis for Sickle Cell Anemia
Kangpu Xu, Zhong Ming Shi, Lucinda L. Veeck, Mark R. Hughes, and Zev Rosenwaks
JAMA. 1999;281(18):1701-1706.
ABSTRACT
| FULL TEXT
Depressed Adolescents Grown Up
Myrna M. Weissman, Susan Wolk, Risë B. Goldstein, Donna Moreau, Philip Adams, Steven Greenwald, Claudia M. Klier, Neal D. Ryan, Ronald E. Dahl, and Priya Wickramaratne
JAMA. 1999;281(18):1707-1713.
ABSTRACT
| FULL TEXT
The Definition of Anemia in Older Persons
Gerbrand J. Izaks, Rudi G. J. Westendorp, and Dick L. Knook
JAMA. 1999;281(18):1714-1717.
ABSTRACT
| FULL TEXT
Malondialdehyde-Modified LDL as a Marker of Acute Coronary Syndromes
Paul Holvoet, Désiré Collen, and Frans Van de Werf
JAMA. 1999;281(18):1718-1721.
ABSTRACT
| FULL TEXT
The Safety of Newly Approved Medicines: Do Recent Market Removals Mean There Is a Problem?
Michael A. Friedman, Janet Woodcock, Murray M. Lumpkin, Jeffrey E. Shuren, Arthur E. Hass, and Larry J. Thompson
JAMA. 1999;281(18):1728-1734.
ABSTRACT
| FULL TEXT
Anthrax as a Biological Weapon: Medical and Public Health Management
Thomas V. Inglesby, Donald A. Henderson, John G. Bartlett, Michael S. Ascher, Edward Eitzen, Arthur M. Friedlander, Jerome Hauer, Joseph McDade, Michael T. Osterholm, Tara O'Toole, Gerald Parker, Trish M. Perl, Philip K. Russell, Kevin Tonat, and for the Working Group on Civilian Biodefense
JAMA. 1999;281(18):1735-1745.
ABSTRACT
| FULL TEXT
Advances in Molecular Genetics and Management of Hypertrophic Cardiomyopathy
Lameh Fananapazir
JAMA. 1999;281(18):1746-1752.
EXTRACT
| FULL TEXT
|
